Digestive Diseases and Sciences

, Volume 50, Issue 5, pp 807–808 | Cite as

Need for Guidelines in Gastroenterology for the General Practitioner

  • Yaron Niv
Review Article


General practitioners base their clinical strategy on evidence-based medicine and experience. When prospective randomized controlled studies have not provided an answer to a specific clinical question, or when common practice in a certain area is not well established, guidelines formulated by specialists with in-depth knowledge of the field are needed. Studies have shown that gastroenterology guidelines have improved the approach to Helicobacter pylori infection and the management of gastroesophageal reflux disease. Failure to use these guidelines by general practitioners can lead to diagnostic inconsistencies and faulty patient care. This is particularly important in Israel, where the heterogeneous patient and physician populations are characterized by differences in the interpretation of symptoms, disease prevalence, and education.

Key Words

guidelines gastroenterology primary care family physician 


  1. 1.
    Ruszniewski P, Bergmann JF, Jian R: What does the term “gastritis” mean for the general practitioners? Gastroenterology 114:A37 (G0153), 1998Google Scholar
  2. 2.
    Perlstein PH, Kotagal UR, Bolling C, Steele R, Schoettker PJ, Atherton HD, Farrell MK: Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics 104:1334–1341, 1999CrossRefPubMedGoogle Scholar
  3. 3.
    Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ: An evidence-based appraisal of reflux disease management—The Genval Workshop Report. Gut 44(Suppl 2):S1–S16, 1999PubMedCrossRefGoogle Scholar
  4. 4.
    Malfertheiner P, Megraud F, O’Morain C, Hungins APS, Jones R, Axon A, Graham DY, Tytgat G: Current concepts in the management of Helicobacter pylori infection —The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16:167–180, 2000CrossRefGoogle Scholar
  5. 5.
    Silverstein FE, Graham DY, Senior JR: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 123:241–249, 1995PubMedGoogle Scholar
  6. 6.
    Abuksis G, Mor M, Plaut S, Fraser G, Niv Y: Delayed insertion of percutaneous endoscopic gastrostomy: a new approach. Presented at the First European Meeting of Ethics in Gastroenterology, Kos, Greece, June 2002Google Scholar
  7. 7.
    Wolfe MM, Lichtenstein DR, Singh G: Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs. N Engl J Med 340:1888–1899, 1999CrossRefPubMedGoogle Scholar
  8. 8.
    Griffin MR, Scheiman JM: Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity. Am J Med 110(1A):33S–37S, 2001CrossRefPubMedGoogle Scholar
  9. 9.
    Niv Y, Birkenfeld S: A need for guidelines for GERD for the primary-care physician. IMAJ 4:684–686, 2002PubMedGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Yaron Niv
    • 1
    • 2
  1. 1.Department of Gastroenterology, Rabin Medical Center, Beilinson CampusTel Aviv UniversityIsrael
  2. 2.Department of GastroenterologyRabin Medical CenterPetach TikvaIsrael

Personalised recommendations